Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sinjini Sarkar
Observed names:
Dr. Sinjini Sarkar,
S. Sarkar
Institutions:
Narsee Monjee Institute of Management Studies,
Shri Vile Parle Kelavani Mandal
Observed institutions:
University of Calcutta,
Jadavpur University,
Narsee Monjee Institute of Management Studies,
Chittaranjan National Cancer Institute,
Shri Vile Parle Kelavani Mandal
ORCID:
0000-0003-1053-8560
Observed ORCID:
0000-0003-1053-8560
OpenAlex ID:
A5030215935
Mitotic checkpoint defects: en route to cancer and drug resistance
2021
·
Sinjini Sarkar
, Pranab Kumar Sahoo
, et al.
·
Chromosome Research
·
55
PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
2022
·
Sutapa Mahata
, Pranab K. Sahoo
, et al.
·
Medical Oncology
·
26
In-silico and in-vitro investigation of STAT3-PIM1 heterodimeric complex: Its mechanism and inhibition by curcumin for cancer therapeutics
2022
·
Sutapa Mahata
, Santosh Kumar Behera
, et al.
·
International Journal of Biological Macromolecules
·
24
PDF
Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India
2022
·
Sinjini Sarkar
, Pranab K. Sahoo
, et al.
·
Supportive Care in Cancer
·
16
Human Papillomavirus Infections in Pregnant Women and Its Impact on Pregnancy Outcomes: Possible Mechanism of Self-Clearance
2020
·
Sanchita Roy Pradhan
, Sutapa Mahata
, et al.
·
IntechOpen eBooks
·
10
PDF
Sociodemographic factors and clinical presentation of women attending Cancer Detection Centre, Kolkata for breast examination
2020
·
Sinjini Sarkar
, Dipanwita Ghosh
, et al.
·
Journal of Clinical and Translational Research
·
9
Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study
2020
·
Pranab Kumar Sahoo
, Sinjini Sarkar
, et al.
·
European Journal of Cancer Prevention
·
7
Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC
2023
·
Tanuma Mistry
, Arijit Nath
, et al.
·
American Journal of Clinical Oncology
·
5
Evaluation of numerical rating scale and neuropathic pain symptom inventory pain scores in advanced ovarian carcinoma patients undergoing surgery and first-line chemotherapy
2022
·
Sinjini Sarkar
, Ranita Pal
, et al.
·
Journal of Clinical and Translational Research
·
5
PDF
Polymorphism of Transporter Genes Contributes to Variations in Treatment Outcomes and Adverse Events in Platinum Based- Chemotherapy- Treated Oral Cancer Patients
2024
·
Pranab Kumar Sahoo
, Tanuma Mistry
, et al.
·
Precision Oncogenomics
·
3
Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle-assembly Checkpoint
2024
·
Sinjini Sarkar
, Ranita Pal
, et al.
·
Indian Journal of Public Health
·
3
Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study
2024
·
Pranab Kumar Sahoo
, Anup Kumar Bhowmick
, et al.
·
Journal of Cancer Research and Therapeutics
·
3
187P BUB1 (2530C>T) polymorphism and expression affects chemotherapy response and predicts poor prognosis in advanced epithelial ovarian cancer
2022
·
S. Sarkar
, P.K. Sahoo
, et al.
·
Annals of Oncology
·
3
CAR-T Cell Therapy: Illuminating the Path to Solid Tumour Recovery
2025
·
Dipanjan Karati
, Sinjini Sarkar
, et al.
·
Frontiers in Cell Science
·
2
Socio-demographic Characteristics and Use of Pap Smear for Cervical Cancer Screening Among Women of Eastern Part of India
2019
·
Dipanwita Ghosh
, Sutapa Mahata
, et al.
·
Indian Journal of Gynecologic Oncology
·
2
Clinicopathological insights and prognostic implications of DEK in association with apoptosis-regulating factors in ovarian cancer
2025
·
Trisha Choudhury
, Ranita Pal
, et al.
·
Clinical & Translational Oncology
·
1
Checkpoint Genes in Check: Impact of BUB1, BUB1B, and MAD2 Alterations on the Treatment Outcomes of Advanced Ovarian Cancer
2025
·
Sinjini Sarkar
, Ranita Pal
, et al.
·
Journal of Current Oncological Trends
·
1
Effect of overexpression of ERK1/2 and MDR1 on chemoresistance in advanced gastric cancer patients.
2023
·
Sushmita Ghosh
, Ranita Pal
, et al.
·
Journal of Clinical Oncology
·
1
CLO22-081: Clinical Efficacy and Quality of Life of Oral Cancer Patients Treated With Paclitaxel/Cisplatin/5-FU Vs Paclitaxel/Carboplatin Chemotherapeutic Regimens in a Tertiary Cancer Center in Eastern India
2022
·
Pranab Kumar Sahoo
, Sinjini Sarkar
, et al.
·
Journal of the National Comprehensive Cancer Network
·
1
Organoids and AI-integrated models in ovarian cancer research: the future of personalized therapy
2026
·
Anuradha Nikam
, Gyamcho Tshering Bhutia
, et al.
·
Frontiers in Oncology
PDF
CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer
2026
·
Swarupananda Mukherjee
, Dipanjan Karati
, et al.
·
Nanomedicine
The Role of MicroRNAs in the Onset and Progression of Alzheimer’s Disease: An Explicative Overview
2026
·
Sinjini Sarkar
·
BENTHAM SCIENCE PUBLISHERS eBooks
Neuroinflammation mediated repurposing of clemastine for Alzheimer’s disease through network pharmacology, molecular dynamics, and experimental validation studies
2026
·
Simran Soni
, Sinjini Sarkar
, et al.
·
Inflammopharmacology
Synergistic Topical Therapy for Squamous Cell Carcinoma via Mixed Micelles Co-delivering 5-Fluorouracil and Genistein
2026
·
Vidhi Sharma
, Sinjini Sarkar
, et al.
·
Journal of Pharmaceutical Innovation
Nanocarrier in Gene Therapy
2025
·
Sinjini Sarkar
, Swarupananda Mukherjee
, et al.
·
CRC Press eBooks
Show more works
View as search
Works count:
31
Citation count:
177
H-index:
7
I10-index:
5
Year
Topic
Type